MDAI – is also known as 5,6-Methylenedioxy-2-aminoindane, and is a compound developed in the 1990s by a team led by David E. Nichols at Purdue University. It acts as a non-neurotoxic and highly selective serotonin releasing agent (SSRA) in vitro and produces entactogen effects in humans. The chemical structure of MDAI is indirectly derived from that of the illicit drug…
Select options
This product has multiple variants. The options may be chosen on the product page
